Negative regulators in cancer immunology and immunotherapy

1Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

It is now well established that the immune system is able to detect and destroy tumors in a process termed tumor immunosurveillance. However, the "dark side" of tumor immunity is immune evasion. That is, by the time a patient suffers from a clinically-detectable tumor, the tumor has already successfully evaded cancer immunosurveillance and often has established effective mechanisms to actively suppress the immune system, particularly in the tumor microenvironment. Therefore, cell contact-dependent and -independent immunosuppressive networks represent a significant barrier to effective immunity and immunotherapy. In this chapter, we describe some of these immunosuppressive mechanisms and components that are linked in complex networks. A better understanding of these mechanisms will eventually lead to improvements of cancer immunotherapies.

Cite

CITATION STYLE

APA

Zimmermann, W., & Kammerer, R. (2011). Negative regulators in cancer immunology and immunotherapy. In Experimental and Applied Immunotherapy (pp. 229–249). Humana Press Inc. https://doi.org/10.1007/978-1-60761-980-2_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free